New Vaccine Recommendations

Tools

Story Updated: Jul 29, 2014

In recent years the effort to protect children and young adults from bacterial meningitis has become a major public health priority. To that end Americans currently have access to 2 different types of approved vaccines: the "conjugate" vaccine and the "polysaccharide" vaccine.

But the American Academy of Pediatrics now says that in nearly all cases the conjugate vaccine should be considered the vaccine of choice. Why? Academy experts have concluded that the conjugate vaccine produces a notably stronger and longer-lasting immune response and therefore better protection. The Academy further stresses that all adolescents should be inoculated between the ages of 11 and 12 followed by a booster at age 16. And up through age of 21- first-year college students living in residential halls whose last vaccination occurred before the age of 16 need another shot.

That said the conjugate vaccine actually comes in 3 specific formulations. So it's important for parents to consult their child's physician to ensure their child gets the most appropriate vaccine available.

I'm Dr. Cindy Haines of HealthDay TV with news from today that can lead to healthy tomorrows.

Add a comment

Name:

Comment: 250 Characters Left

KOFY and its affiliated companies are not responsible for the content of comments posted or for anything arising out of use of the above comments or other interaction among the users. We reserve the right to screen, refuse to post, remove or edit user-generated content at any time and for any or no reason in our absolute and sole discretion without prior notice, although we have no duty to do so or to monitor any Public Forum.